News

TORONTO, CANADA, November 7, 2023—Everest Clinical Research (“Everest”), a leading full-service contract research organization (“CRO”) with deep expertise in clinical data management, biostatistics and statistical programming, today announced it has acquired August Research (“August”). Everest is a portfolio company of Arlington Capital Partners (“Arlington”), a Washington, D.C. based private equity firm with extensive experience investing…

TORONTO, CANADA, December 1, 2022 – Everest Clinical Research (“Everest”), a leading full-service contract research organization (“CRO”) with deep expertise in biostatistics and statistical programming, today announced it has acquired Brightech International (“Brightech”). Founded in 2002, Brightech is a leading CRO that specializes in complex, value-add biostatistics, programming and clinical data management services. Similar to…

By integrating data across disparate systems, insights into trial operations, data integrity and patient information are centralized at your finger tips. Everest has leveraged its strong foundation in data and analytics to provide clinical data dashboard solutions to our clients. The Dashboard initiative brings together data across clinical trial systems – which includes EDC, IWRS/IRT,…

Over the past 16 years we have built a solid foundation for future growth. Our reputation for quality, and strong track record of success support our plan for accelerated growth in 2021 and years beyond. Everest’s growth is accelerating. We have grown steadily and organically for the past 16 years and have focused on delivering…

We are proud to support over a dozen COVID-19 vaccine and therapeutic treatment trials, including high profile time-sensitive multinational trials, to help bring relief to public safety and health, and to those who are suffering. We are inspired by and love the work we do. While our work has always driven meaningful impact to addressing…

During the COVID-19 pandemic, Everest team members are safe and healthy. Our commitment, high performance, and level of customer service remains as high as before the pandemic. Everest has been fortunate to be nominally impacted by the coronavirus COVID-19 pandemic as employees are able to work seamlessly from home. During 2020, we persevered with our…

Despite the significant advances made in finding treatments for human diseases, there remains an unmet need in oncology research. Approximately one-third of Everest’s clinical research projects are trials for cancer treatments. Diverse and deep oncology experience. Oncology clinical research development is a passion and an area of strong expertise of Everest. We pride ourselves on…